HerbertStuart BlockBarafMDFACP, MACR
Rheumatology • Bethesda, MDCrystal Related
Special Volunteer, NIAMS
Dr. Baraf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Edgemoor Ln
Bethesda, MD 20814
Education & Training
Duke University HospitalFellowship, Rheumatology, 1976 - 1978
George Washington UniversityResidency, Internal Medicine, 1973 - 1976
State University of New York Downstate Medical Center College of MedicineClass of 1973
University of MichiganBachelor of Science, 1965 - 1969
Certifications & Licensure
MD State Medical License 1978 - 2026
DC State Medical License 1974 - 2013
NC State Medical License 1976 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Innovation in Clinical Medicine Award American College of Rheumatology, 2022
- Herbert Baraf Excellence in Arthritis Care Award (inaugural recipient) Arthritis Foundation - Metro DC, 2022
- Paulding Phelps Award American College of Rheumatology, 2014
- Join now to see all
Publications & Presentations
PubMed
- 68 citationsTophus burden reduction with pegloticase: Results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapyHerbert S B Baraf, Michael Becker, Sergio R. Gutierrez-Urena, Edward L. Treadwell, Janitzia Vázquez-Mellado
Arthritis Research & Therapy. 2013-09-26 - 10 citationsEarly effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and...Yusuf Yazici, Jeffrey R. Curtis, A Ince, Herbert S B Baraf, Denise M Lepley
Clinical and Experimental Rheumatology. 2013-01-10 - 155 citationsEvaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.Désirée van der Heijde, Herbert S B Baraf, Cesar Ramos-Remus, Andrei Calin, Arthur L. Weaver
Arthritis and Rheumatism. 2005-04-01
Press Mentions
Gout: Combining 2 Existing Drugs Doubles Treatment Success in New StudyMay 20th, 2021
Practice & Society Donations Advance Advocacy Efforts for Rheumatologists & PatientsOctober 3rd, 2019- Private Practice in Rheumatology: Winners & Losers in the Workforce Numbers GameJuly 25th, 2018
- Join now to see all
Professional Memberships
- Master
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
